Dr. Yu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9135 SW Barnes Rd
Ste 763
Portland, OR 97225Phone+1 503-216-8250Fax+1 971-282-0116
Education & Training
- 2nd Affiliated Hospital, Zhejiang University school of medicinePhD, Cardiovascular diseases, 2006 - 2011
- Tianjin Medical UniversityClass of 2006
Certifications & Licensure
- OR State Medical License 2019 - 2025
- CA State Medical License 2017 - 2019
- VA State Medical License 2017 - 2017
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 5 citationsA vascular smooth muscle cell X-box binding protein 1 and transglutaminase 2 regulatory circuit limits neointimal hyperplasia.Ramon L. Serrano, Weifang Yu, Robert M. Graham, Ru Liu Bryan, Robert Terkeltaub
Plos One. 2019-04-03 - 9 citationsMono-allelic and bi-allelic ENPP1 deficiency promote post-injury neointimal hyperplasia associated with increased C/EBP homologous protein expressionRamon L. Serrano, Weifang Yu, Robert Terkeltaub
Atherosclerosis. 2014-04-01 - 22 citationsRAGE signaling mediates post-injury arterial neointima formation by suppression of liver kinase B1 and AMPK activityWeifang Yu, Ru Liu-Bryan, Stephanie Stevens, Jagadeesha K. Damanahalli, Robert Terkeltaub
Atherosclerosis. 2012-06-01
Research History
- Postdoc fellowVMRF UCSD, San Diego, CA2010 - 2013
- Postdoc fellowIn Brigham and Women's Hospital, Harvard Medical School, Boston, MA2008 - 2010
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: